Inactive Instrument

Press Releases Addex Therapeutics Ltd Xetra

Equities

APE

CH0029850754

Press Releases

Unlock all the news: Be the first to know and act before the market!

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)	15/07	GL
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)	12/07	GL
Addex Shareholders Approve All Resolutions at Annual General Meeting	01/07	GL
ADDEX THERAPEUTICS : INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Form 6 K	06/06	PU
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update	06/06	GL
Addex Convenes Annual General Meeting 2024	05/06	GL
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024	31/05	GL
Addex to Present at Bio€quity Europe 2024	08/05	GL
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	29/04	GL
Addex to Present at the Swiss Biotech Day 2024	19/04	GL
Addex to Present at the Swiss Biotech Day 2024	19/04	AQ
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18/04	GL
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18/04	AQ
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024	11/04	GL
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	03/04	GL
Addex to Present at the Bio-Europe Spring 2024 Conference	14/03	GL
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.	31/01	GL
Addex to Present at the Swiss Equities Baader Conference	09/01	GL
Addex to Present at the Swiss Equities Baader Conference	09/01	AQ
Addex to Present at the Swiss Equities Baader Conference	09/01	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Addex Therapeutics Ltd Xetra

Equities

APE

CH0029850754

Press Releases

Filters